Participate in research aimed at relieving hot flushes and night sweats
Participate in research aimed at relieving hot flushes and night sweats experienced by women after breast cancer.
Researchers across several states in Australia are conducting a study to evaluate a potential new treatment aimed at relieving hot
flushes and night sweats in women diagnosed with breast cancer who are
taking hormone blocking therapy (either tamoxifen or an aromatase
inhibitor).
While clinical trials have found hormone blocking
therapy can significantly reduce the risk of breast cancer coming back
(recurring), many women experience menopausal-like symptoms when taking
hormone-blocking therapy. While these side effects are mild for many
women or lessen over time, some women experience significant symptoms
which can be difficult to cope with.
The study will determine
whether QUE 122 (a small molecule which was found to lessen hot flushes
and night sweats in an earlier study) is effective in reducing night
sweats and hot flushes in women affected by breast cancer being treated
with hormone blocking therapy.
You may be eligible to participate if you are:
- Aged 18 to 70 years
- Are taking tamoxifen or an aromatase inhibitor (i.e. anastrozole (Arimidex), letrozole (Femara) or exemestane (Aromasin).
- Are experiencing 7 or more hot flushes/night sweats each day/evening.
- Are able to attend 6 study visits at the research site over approximately 9 weeks.
This study is taking place at sites in Melbourne, Sydney, Adelaide, Brisbane and Perth.
If you are interested in participating or would like further information, please contact the study site closest to you
